[
1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. Erratum in: Lancet. 2013; 381(9867):628. AlMazroa, Mohammad A [added]; Memish, Ziad A [added]
]Search in Google Scholar
[
2. Hinton R, Moody RL, Davis AW, Thomas SF. Osteoarthritis: diagnosis and therapeutic considerations. Am Fam Physician. 2002; 65(5):841-8
]Search in Google Scholar
[
3. Simon C, Everitt H, van Dorp F, Burkes M. Oxford Handbook of General Practice, 14th ed, 2014; Oxford University Press; p. 512-51310.1093/med/9780199671038.001.0001
]Search in Google Scholar
[
4. Hampton SN, Nakonezny PA, Richard HM, Wells JE. Pain catastrophizing, anxiety, and depression in hip pathology. Bone Joint J. 2019; 101-B (7):800-807.10.1302/0301-620X.101B7.BJJ-2018-1309.R131256659
]Search in Google Scholar
[
5. Meenan RF, Mason JH, Anderson JJ, Guccione AA, Kazis LE. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum. 1992; 35(1):1-1010.1002/art.17803501021731806
]Search in Google Scholar
[
6. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis. 1957; 16(4):494-50210.1136/ard.16.4.494100699513498604
]Search in Google Scholar
[
7. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol. 1988; 15(12):1833-40.
]Search in Google Scholar
[
8. Schiphof D, de Klerk BM, Kerkhof HJ, Hofman A, Koes BW, Boers M, et.al. Impact of different descriptions of the Kellgren and Lawrence classification criteria on the diagnosis of knee osteoarthritis. Ann Rheum Dis. 2011; 70(8):1422-710.1136/ard.2010.14752021555325
]Search in Google Scholar
[
9. Taruc-Uy RL, Lynch SA. Diagnosis and treatment of osteoarthritis. Prim Care. 2013; 40(4):821-3610.1016/j.pop.2013.08.00324209720
]Search in Google Scholar
[
10. van Spil WE, DeGroot J, Lems WF, Oostveen JC, Lafeber FP. Serum and urinary biochemical markers for knee and hiposteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage. 2010; 18(5):605-1210.1016/j.joca.2010.01.01220175979
]Search in Google Scholar
[
11. Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest. 2006; 116(1):4-1510.1172/JCI27291132326916395396
]Search in Google Scholar
[
12. McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et.al. Effect of intra-articular Triamcinolone vs Saline on knee cartilage volume and pain in patients with knee osteoarthritis: A randomized clinical trial. JAMA. 2017; 317(19):1967-197510.1001/jama.2017.5283581501228510679
]Search in Google Scholar
[
13. Grosser T et al, J. Clin. Invest. 2006, 116:4–15
]Search in Google Scholar
[
14. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; 180:11414710.1016/j.bcp.2020.114147734750032653589
]Search in Google Scholar
[
15. Machado GC, Abdel-Shaheed C, Underwood M, Day RO. Nonsteroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain. BMJ. 2021;372: n10410.1136/bmj.n10433514562
]Search in Google Scholar
